CLINICAL_TRIALS
research
· 2021-02-24
Clinical Trial Update: Low Plasma Mannose Binding Lectin (p-MBL) Level is a Risk Factor for Recurrent Pregnancy Loss (RPL)
Summary
Clinical trial completed examining low plasma mannose-binding lectin levels as a risk factor for recurrent pregnancy loss.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Aalborg University Hospital | Conditions: Recurrent Miscarriage, Spontaneous Abortion | Status: COMPLETED | Results posted: 2021-02-24